PMC:7234792 / 4170-4321
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 90 | 12-24 | Chemical | denotes | azithromycin | MESH:D017963 |
| 91 | 68-79 | Chemical | denotes | clindamycin | MESH:D002981 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T65 | 38-39 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T44 | 12-24 | Chemical | denotes | azithromycin | http://purl.obolibrary.org/obo/CHEBI_2955 |
| T45 | 68-79 | Chemical | denotes | clindamycin | http://purl.obolibrary.org/obo/CHEBI_3745 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T28 | 0-151 | Sentence | denotes | Intravenous azithromycin (500 mg once a day) was restarted and oral clindamycin (300 mg once every 6 h) was administered, without clinical improvement. |